404 related articles for article (PubMed ID: 16563187)
1. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
2. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
Shivakumar S; Tsokos GC; Datta SK
J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
[TBL] [Abstract][Full Text] [Related]
4. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
Funauchi M; Sugishima H; Minoda M; Horiuchi A
J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936
[TBL] [Abstract][Full Text] [Related]
5. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
6. In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon.
Braude IA; Hochberg MC; Arnett FC; Waldmann TA
J Rheumatol; 1988 Mar; 15(3):438-44. PubMed ID: 3132556
[TBL] [Abstract][Full Text] [Related]
7. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
8. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
9. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Huang YP; Perrin LH; Miescher PA; Zubler RH
J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
[TBL] [Abstract][Full Text] [Related]
10. Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.
Kaneoka H; Morito F; Yamaguchi M
J Clin Lab Immunol; 1989 Jan; 28(1):15-26. PubMed ID: 2470907
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between serum interleukin-4 or interferon-gamma level and B cell abnormality in patients with collagen vascular diseases].
Funauchi M; Minoda M; Horiuchi A
Ryumachi; 1991 Oct; 31(5):493-501. PubMed ID: 1767343
[TBL] [Abstract][Full Text] [Related]
12. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
[TBL] [Abstract][Full Text] [Related]
13. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
Hirose T
Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
[TBL] [Abstract][Full Text] [Related]
14. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
15. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
Glinski W; Gershwin ME; Steinberg AD
J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.
Bankhurst AD; Williams RC
J Clin Invest; 1975 Dec; 56(6):1378-85. PubMed ID: 1081549
[TBL] [Abstract][Full Text] [Related]
17. [Role of T lymphocytes in systemic lupus erythematosus].
Zubler RH; Miescher PA
Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
[TBL] [Abstract][Full Text] [Related]
18. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
Volk HD; Diamantstein T
Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
[TBL] [Abstract][Full Text] [Related]
19. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
Katagiri T
Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
[TBL] [Abstract][Full Text] [Related]
20. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]